Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial ResultsPRNewsWire • Tuesday
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field TrialsPRNewsWire • 11/12/24
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule DesignPRNewsWire • 10/31/24
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in KenyaPRNewsWire • 10/29/24
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing TechnologyPRNewsWire • 10/08/24
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-BiologicalsPRNewsWire • 09/30/24
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private PlacementPRNewsWire • 08/23/24
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in BrazilPRNewsWire • 07/31/24
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-StimulantsPRNewsWire • 07/17/24
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African CountryPRNewsWire • 06/25/24
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & MelanomaPRNewsWire • 05/23/24
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor SeedsPRNewsWire • 05/21/24